Top Markets
#1 bitcastle Token bitcastle Token +151.43%
#2 MarsCoin MarsCoin +70.18%
#3 Palladium Network Palladium Network +53.05%
#4 Siren Siren +28.27%
#5 edgeX edgeX +23.02%
#6 Status Status +20.93%
#7 Useless Coin Useless Coin +18.68%
#8 Bedrock Bedrock +18.28%
#9 PondCoin PondCoin +15.49%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
Coin of the day
bitcastle Token bitcastle Token
Settings
Language
ENGLISH
Currency
USD
Theme
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
Rank in Stocks #18598
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Share Price
$2.88
Market Cap
$192.66M
Change (1 day)
-0.55%
Change (1 year)
-59.61%
Country
TW
Trade Alar Pharmaceuticals Inc. (6785)

Category

Healthcare
Number of shares outstanding for Alar Pharmaceuticals Inc. (6785)
Number of shares outstanding as of September 2026: 0
According to Alar Pharmaceuticals Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Alar Pharmaceuticals Inc. (6785) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 445.06M -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 18.05B -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT